Prof. Dr. Soley Bayraktar, a specialist in hematology and medical oncology with experience in some of the most successful oncology hospitals in the world, will visit Sofia on March 31 and April 1. Cancer patients from Bulgaria will have the opportunity to consult for free with Assoc. Bayraktar, who is coming to Bulgaria at the invitation of the Health Information Center "Medical Karaj", as part of their initiative to provide Bulgarian patients with access to the most advanced methods in medicine, partnering with some of the best medical institutions and specialists from around the world in each medical field.
Associate Professor Dr. Soley Bayraktar graduated in medicine from Hacettepe University in 2003 and went to the USA where he specialized in medical oncology and hematology and worked until 2015. Her career has taken her through some of the most reputable cancer centers in the world, including MD Anderson and Mercy Cancer Center. She has been involved in research on the role of genistein and lycopene in cancer survival, as well as phase 1-3 clinical trials in pancreatic and colon cancer. He is the recipient of numerous professional awards and honors, including from the American Society of Clinical Oncology (ASCO) and Wayne State University in Detroit. Since 2015, he has been part of the team at the Cancer Center at Memorial Shishli Hospital in Turkey, where individualized innovative therapies tailored to each patient's specific needs are applied, increasing treatment success rates and reducing adverse side effects.
The latest in cancer treatment
Cancer treatment is one of the areas where most innovative advances and knowledge accumulation have taken place in recent years. The "One size fits all" model has been replaced by the "individual therapy" method. So-called "smart" drugs and antibody therapies that target only the cancer cells increase the patient's life expectancy and quality of life. By recognising certain antigenic structures in the cancer tissue, they destroy only these cells and at the same time minimise damage to healthy tissues. In this way, problems that may cause adverse effects in the patient are eliminated.
Genetics of cancer
In 5 to 10% of cases, the cancers are hereditary. If several people in the same family have developed cancer with the same or similar location, it is possible that this is due to a genetic predisposition. In such cases, cancer is usually diagnosed at a younger age, often even before the age of 50. At Memorial Hospital's Genetic Cancer Clinic, the risk of hereditary cancer is determined using a genetic test that examines a blood sample for specific changes in DNA and genetic information. Depending on the results, specific recommendations may be given.
Cancer patients from Bulgaria can take the opportunity for free consultations with Dr. Soley Bayraktar on March 31 and April 1, 2017. They will be required to provide all medical epithelials describing treatment to date, as well as up-to-date investigations in English on site. Pre-registration is required by calling "Medical Karaj": 0879 977 402 or 0879 977 401.
